Estonian HealthTech Delegation Visit to the United Kingdom
From 6–8 October, Estonia’s HealthTech delegation joined President Alar Karis on an official visit to the United Kingdom. A three-day journey to showcase Estonia’s growing health innovation ecosystem, strengthen collaboration with British partners, and highlight our shared vision for the future of healthcare: data-driven, prevention-focused, and built on trust.
Together with our partners and 16 HealthTech startups and research organisations, we spent three inspiring days in London and Cambridge, exploring new opportunities for cooperation with some of the UK’s leading institutions, including King’s College London, UCLPartners, NIHR (National Institute for Health and Care Research), Cambridge Biomedical Campus, Cambridge University Health Partners, and Innovate Cambridge.
Each meeting reaffirmed how much our ecosystems have in common: a shared ambition to turn innovation into meaningful impact and a belief that collaboration between research, technology, and healthcare can transform lives. Throughout the visit, one theme stood out — the potential for Estonian–British partnership in HealthTech has never been stronger. The UK’s world-class research landscape and the NHS’s drive for innovation align naturally with Estonia’s experience in building digital-first, trust-based healthcare systems.
“We’re committed to advancing a healthcare future that’s powered by technology, grounded in trust, and designed to truly improve lives,” said Merit Vislapu, Project Lead at Health Founders Estonia. “Meeting inspiring people, potential partners, and mentors in London and Cambridge reinforced the strong connection between our ecosystems and the shared ambition to drive innovation in healthcare. Together, we’re building a future where technology empowers better health for all.”
The Estonian delegation brought together a diverse mix of innovators shaping the future of care from digital health pioneers to biotechnology leaders and research institutions. Participating organisations included: Antegenes, Better Medicine, Chemestmed, Health Founders Estonia, Kodality, Lifeyear, Menken Trials, Mentastic, Migrevention, Mu-ray.tech, Muun Health, Power Algae, Solis BioDyne, Tallinna Tervishoiu Kõrgkool / Tallinn Health University of Applied Sciences, TBD Pharmatech, Tehnopol HealthTech, and Thorgate.
Across every conversation, one message resonated clearly — innovation travels best through collaboration. The bridges built between Estonia and the UK during this visit highlight our shared drive to advance health technologies that are smarter, more connected, and focused on prevention and patient trust.
The visit was co-organised by Enterprise Estonia’s investment and trade departments and the Estonian Embassy in London, with collaborators from Health Founders Estonia and Tehnopol Science and Business Park. The visit was funded by the European Union NextGenerationEU.
The HFE program is funded by the EU through Enterprise Estonia, in collaboration with Startup Estonia, to build a strong, globally competitive health tech ecosystem in Estonia.